Bimini Health Tech
Bimini Health Tech is a privately held medical device and biologics company developing adipose filtration systems, acellular dermal matrices, and structured saline breast implants for plastic and reconstructive surgeons worldwide, with products used in over 1.5 million procedures across 50+ countries.
- Company typePrivate
- Founded2013
- HeadquartersPlano, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Bimini Health Tech does
Bimini Health Tech is a privately held, commercial-stage medical device and biologics company founded in 2013 and headquartered in Plano, Texas. The company develops and markets a portfolio of tissue and cell-based technologies focused on women's health — specifically breast reconstruction — as well as adjacent applications in aesthetics, minimally invasive procedures, and orthopedics. Its core product lines include the PureGraft family of adipose filtration systems (74-micron dialyzing filter technology achieving up to 97% pure fat grafts, available in 50/250/850mL sizes plus Puregraft SYNC single-use disposables and PureGraft Boost micronizers), Essence acellular dermal matrix (ADM), Serene Structured Saline Breast Implants (acquired from Ideal Implant in August 2023 and FDA Class III approved), Dermapose office-based microfat transfer systems, and Healeon PRP blood separation products (with select aesthetic assets divested to Crown Laboratories in July 2024). The portfolio is supported by over 100 patents, 20+ device clearances, and ISO 13485/MDSAP certifications, with products used in 1.5M+ procedures across 50+ countries.
Bimini operates a sales-led, direct-to-physician go-to-market model targeting plastic and reconstructive surgeons, aesthetic physicians, and orthopedic specialists through field sales, physician education programs (Bimini Academy), and KOL communities (Bimini Connect). Revenue is generated primarily through one-time hardware sales of capital devices and recurring sales of single-use disposables, with quote-based pricing that is not publicly disclosed. The company has expanded internationally through the OPALINE Aesthetics joint venture with GC Aesthetics (October 2023), giving it mutual distribution access across US, LATAM, EMEA, and APAC, and secured EU MDR certification in May 2026. Recent FDA 510(k) clearances for Float PRP (November 2024) and Puregraft SYNC (February 2026), along with Essence ADM size expansion, demonstrate an active regulatory and product development cadence. Leadership is led by founder/CEO Bradford A. Conlan with a lean executive team including COO Lucas Fornace and CCO Jeff Greiner.
Bimini Health Tech firmographics
Firmographics- Name
- Bimini Health Tech
- Legal name
- Bimini Health Tech
- Website
- https://biminihealthtech.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Bimini Health Tech is a privately held medical device and biologics company developing adipose filtration systems, acellular dermal matrices, and structured saline breast implants for plastic and reconstructive surgeons worldwide, with products used in over 1.5 million procedures across 50+ countries.
- Ownership category
- akta.pro rank
Bimini Health Tech industry classification
Industry- Product category
- Medical Devices - Plastic and Reconstructive Surgery
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113), Surgical and Medical Instrument Manufacturing (339112), Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Wound Healing & Skin Regeneration (advanced dressings, skin substitutes) (HLAAAGAG)
Keywords
Where Bimini Health Tech is headquartered
LocationHeadquarters
- HQ city
- Plano
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Bimini Health Tech business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Marketing or Sales, Personnel, Infrastructure
Revenue model
- Medical Device Sales: Bimini Health Tech generates revenue through the sale of medical devices and biologics including fat transfer systems (Puregraft family), breast implants (Serene), acellular dermal matrices (Essence ADM), and PRP systems (Healeon). Products are sold directly to physicians and healthcare providers for use in surgical procedures.
- Disposable/Single-Use Products: Revenue from single-use disposable products including Puregraft filtration bags, Puregraft SYNC systems, Dermapose Refresh devices, and Healeon PRP tubes. These generate recurring revenue through repeat purchases by healthcare providers.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Bimini Health Tech products are medical devices sold directly to healthcare providers. No public pricing available. |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels6 records
Bimini Health Tech product offering
Product offeringCore offering
Bimini Health Tech develops, manufactures, and commercializes proprietary medical devices and biologics for breast reconstruction, fat transfer, and regenerative medicine. Its portfolio centers on the PureGraft family of adipose filtration systems, Essence Acellular Dermal Matrix, Serene Structured Saline Breast Implants, Dermapose microfat transfer systems, and Healeon PRP preparation products. Products are sold directly to plastic surgeons, reconstructive surgeons, and aesthetic physicians for use in surgical and office-based procedures.
Product overview
Bimini Health Tech is a medical device and biologics company offering a comprehensive portfolio of tissue and cell-based technologies focused on women's health, specifically breast reconstruction. The product portfolio centers on the PureGraft family of adipose filtration systems (including PureGraft 50/250/850, Puregraft SYNC, and PureGraft Boost micronizer) for fat transfer procedures, complemented by Essence ADM (acellular dermal matrix) for soft tissue support. The company also offers Serene Structured Saline Breast Implants (acquired through Ideal Implant) for breast augmentation and reconstruction, Dermapose microfat transfer system for office-based procedures, and Healeon PRP products for platelet-rich plasma applications. Pipeline products include Kerastem hair therapy. The portfolio is supported by over 100 patents, 20 device clearances, and used in over 1.5 million procedures worldwide across 50+ countries.
Differentiator
Problem solved
Functional benefit
Brands
- PureGraft: Gold standard adipose filtration systems for fat transfer procedures, available in 50, 250, and 850 mL options plus Puregraft SYNC and Puregraft Boost.
- Essence ADM
- Serene Breast Implant
- Dermapose
- Healeon
- Kerastem
- Bimini Connect
- Bimini Academy
- OPALINE Aesthetics
Products and services
- PureGraft Adipose Filtration System (50, 250, 850 mL) Gold-standard fat grafting filtration system delivering 97% pure fat grafts through proprietary 74-micron dialyzing filter technology. Available in 50, 250, and 850 mL sizes for plastic and reconstructive surgeons performing face, breast reconstruction, and Brazilian butt lift procedures.
- Puregraft SYNC Single-use disposable adipose filtration system providing streamlined fat processing with all-in-one design, integrated Puregraft filtration bag, and automated waste evacuation for harvesting up to 500mL of high-quality fat. Designed for plastic and reconstructive surgeons seeking minimal setup.
- PureGraft Boost Adipose Micronizer Closed micronizing device that resizes purified fat into micro, milli, and nanofat using dual blade technology with diamond-cut screens (500, 1000, 1500 micron), enabling injection through small cannulas.
- Essence Acellular Dermal Matrix (ADM) Ready-to-use, terminally sterile human acellular dermal matrix for plastic and reconstructive surgery. Available in multiple shapes (round, oval, shaped, rectangular) and sizes from 8x16 cm up to 24x26 cm with 0.8mm and 1.2mm thickness options.
- Serene Structured Saline Breast Implant FDA-approved structured saline breast implant with patented multi-shell design featuring inner and outer silicone shells with nested baffle shells. Provides natural look and feel of silicone with adjustable volume and saline fill.
- Dermapose Microfat Transfer System All-in-one office-based system for harvesting, purifying, microsizing, and transferring microfat as a natural alternative to synthetic dermal fillers. Dual-chamber system produces approximately 15-30 cc of pure viable microfat in under 60 minutes.
- Healeon HD PRP Blood separation system for generating platelet-rich plasma (PRP) in office settings. Available in 15 and 30 mL tubes producing 2x or 4x platelet concentrations with separating gel technology capturing 85%+ platelets and removing 99% of red blood cells in a single 10-minute centrifuge cycle.
- Float PRP Next-generation platelet-rich plasma preparation system providing rapid and efficient concentration of platelets and growth factors at point of care. Cleared via U.S. 510(k) Class II.
- Kerastem Hair Therapy Pipeline product for hair loss therapy in androgenetic alopecia using autologous adipose-derived regenerative cells (ADRCs) combined with purified adipose tissue. CE mark approved and undergoing clinical trials; not yet available in the US.
Quantifiable outcome
- 97% pure fat grafts achieved with Puregraft filtration technology
- +4 more outcomes
Companies that use Bimini Health Tech
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles3 records
Bimini Health Tech technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature6 records
Bimini Health Tech partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor and core.
- Motiva (Establishment Labs)minorCollaboration on documentary project 'Reclaiming Confidence' showcasing breast cancer recovery. Motiva provides their next-generation MR Conditional Breast Tissue Expander (Motiva Flora) for the documentary featuring survivor stories and medical innovation.
- CO2Lift (Lumisque Skincare)minorCollaboration on documentary project 'Reclaiming Confidence'. CO2Lift contributes their physician-developed carboxytherapy technology to the project showcasing innovative breast cancer recovery solutions.
- Crown LaboratoriesminorBimini divested select Healeon PRP aesthetic assets to Crown Laboratories. Crown markets acquired PRP products under ProGen Eclipse branding. This divestiture allows Bimini to focus on women's health while Crown expands aesthetic PRP portfolio.
- GC AestheticscoreJoint venture partnership called 'OPALINE Aesthetics' combining GC Aesthetics' 40 years of breast implant experience with Bimini's reconstruction innovations. GC Aesthetics distributes Bimini's products outside US and Canada, while Bimini commercializes GC Aesthetics' breast reconstruction solutions in the US. This partnership covers USA, LATAM, EMEA, and APAC regions with goal of providing best-in-class breast reconstruction solutions globally.
- RevanceminorListed as a trusted partner of Bimini Health Tech. Nature of partnership not explicitly detailed in available sources.
- Genesis BiologicsminorListed as a trusted partner of Bimini Health Tech. Nature of partnership not explicitly detailed in available sources.
- Bausch HealthminorListed as a trusted partner of Bimini Health Tech. Nature of partnership not explicitly detailed in available sources.
- Crown AestheticsminorListed as a trusted partner of Bimini Health Tech. Nature of partnership not explicitly detailed in available sources.
Scale indicators9 records
Recent moves7 records
Expansion highlights6 records
Bimini Health Tech competitors and assessment
Company assessmentBroad incumbents
- Allergan Aesthetics (AbbVie): Broad incumbent selling Natrelle breast implants and AlloDerm acellular dermal matrix; directly competes in Bimini's core breast reconstruction and ADM categories as part of a much larger aesthetics portfolio (Botox, CoolSculpting).
- Stryker: Diversified medtech with growing regenerative and surgical instruments portfolio (including orthobiologics and surgical tools); comparable as a broad incumbent competing for plastic and orthopedic surgery budgets and capital purchasing committees.
- Mentor (Johnson & Johnson MedTech): Global leader in breast implants (MemoryGel, CP4G) sold to plastic surgeons; comparable as a broad incumbent competing for the same plastic surgery accounts and offering silicone and saline implant alternatives to Serene.
Direct peers
- Emcyte Corporation: PRP and autologous regenerative medicine device maker (Concentrated Platelet Rich Plasma kits); directly competes with Healeon HD PRP and Float PRP in orthopedic and aesthetic point-of-care applications.
- Sientra: US breast implant company (silicone gel) acquired by Tiger Aesthetics in 2024; directly comparable as a plastic-surgery focused implant peer with overlapping plastic surgeon customer base and similar regulatory pathway exposure.
- Arthrex: Orthopedics and orthobiologics leader that licenses Bimini's adipose processing technology in its AutoPose system; comparable as a peer in the autologous adipose/orthobiologics space and an explicit commercial partner.
- Integra LifeSciences: Regenerative tissue and ADM manufacturer (Surgimend, PriMatrix, AmnioExcel) selling into plastic surgery, wound care, and breast reconstruction; highly comparable in product type (dermal matrices) and reconstructive surgery call point.
- Establishment Labs (Motiva): Direct competitor in the breast implant and reconstruction market with FDA-cleared Motiva Flora tissue expander and silicone implants; comparable as a women's-health-focused implant company with a similar clinical-evidence and KOL-driven commercial model.
- MTF Biologics: Nonprofit tissue bank that supplies AlloDerm and other ADMs used in breast reconstruction; directly comparable on the Essence ADM side, competing on sheet size, sterility, and surgeon preference.
- GC Aesthetics: European breast implant company (Eurosilicone, Round, Anatomical, Theia) and Bimini's JV partner in OPALINE Aesthetics; directly comparable as a breast implant peer with overlapping surgeon customer base and shared commercial channel.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Bimini Health Tech social profiles
Digital presenceBimini Health Tech compliance and trust
Trust signalCompliance10 records
Bimini Health Tech financial estimates
Financial estimateRevenue estimate
Valuation estimate
Bimini Health Tech leadership team
Management profileNumber of profiles
Profiles4 records
Bimini Health Tech subsidiaries and ownership
Company hierarchySubsidiaries2 records
Bimini Health Tech funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Bimini Health Tech M&A and investment
M&A and investmentM&A3 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Bimini Health Tech
What does Bimini Health Tech do?
Bimini Health Tech develops, manufactures, and commercializes proprietary medical devices and biologics for breast reconstruction, fat transfer, and regenerative medicine. Its portfolio centers on the PureGraft family of adipose filtration systems, Essence Acellular Dermal Matrix, Serene Structured Saline Breast Implants, Dermapose microfat transfer systems, and Healeon PRP preparation products. Products are sold directly to plastic surgeons, reconstructive surgeons, and aesthetic physicians for use in surgical and office-based procedures.
Is Bimini Health Tech a public or private company?
Bimini Health Tech is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Bimini Health Tech founded?
Bimini Health Tech was founded in 2013. It employs 11 to 50 people.
Where is Bimini Health Tech based?
Bimini Health Tech is headquartered in Plano, United States, in the North America region.
How does Bimini Health Tech make money?
Two revenue lines are on record. Medical Device Sales are the primary driver. The others are disposable/Single-Use Products.
Who are Bimini Health Tech's main competitors?
Broad incumbents on record are Allergan Aesthetics (AbbVie), Stryker and Mentor (Johnson & Johnson MedTech). Direct peers are Emcyte Corporation, Sientra, Arthrex, Integra LifeSciences, Establishment Labs (Motiva), MTF Biologics and GC Aesthetics.
Does Bimini Health Tech have an API?
No public API is recorded for Bimini Health Tech.
What industry is Bimini Health Tech in?
Bimini Health Tech's product category is Medical Devices - Plastic and Reconstructive Surgery. Its primary akta.pro industry code is HLAAAGAG, Wound Healing & Skin Regeneration (advanced dressings, skin substitutes). Its NAICS code is 339113 and its SIC code is 3842.